Joanne Marie M. Del Rosario

Author

Also Known As

Del Rosario, Joanne Marie M, J.M. Del Rosario, Joanne Marie Del Rosario, Joanne Marie M. Del Rosario

Publications

130

Citations

H-Index

Concepts

All Affiliations

Joanne Marie M. Del Rosario is an author at Medway School of Pharmacy specializing in vaccine development, vaccination, and immunotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	50
2	Immunology	2	2	50
3	Immunotherapy	2	2	50
4	Vaccine Development	2	2	50
5	Viral Immunity	1	1	21

Joanne Marie M. Del Rosario

Publications

120

Citations

H-Index

Page 1

	Year	Citations
Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity Joanne Marie M. Del Rosario, Matthew D. Smith, Kam Zaki, Frontiers in Immunology	2020	30
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection Joanne Marie M. Del Rosario, Kelly da Costa, Benedikt Asbach, Vaccines VaccinationCross-protectionInfluenza Pseudotype MicroneutralizationVaccine DevelopmentPan Influenza A	2021	29
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants George Carnell, Martina Billmeier, Sneha Vishwanath, Frontiers in Immunology Glycan MaskingImmunologyViral Structural ProteinImmunotherapyBroad-spectrum Vaccines	2023	21
Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies Francesca Ferrara, Joanne Marie M. Del Rosario, Kelly da Costa, Frontiers in Immunology	2021	17
Pseudotyped Viruses for Influenza Joanne Marie M. Del Rosario, Kelly da Costa, Nigel Temperton Advances in experimental medicine and biology	2023	12
Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design Kelly da Costa, Joanne Marie M. Del Rosario, Matteo Ferrari, Vaccines	2022	11

Page 1